Novo Nordisk A/S

FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause.
Women's Health Weekly; 12/17/2009; 985 words; Novo Nordisk said that the U.S. Food and Drug Administration (FDA...Administration, Vagifem, Vaginitis, Women's Health, Novo Nordisk. This article was prepared by Women's Health Weekly editors from staff and...

CBI and Medical Meetings Magazine Announce Agenda for 6th Annual Pharmaceutical Meeting Management Forum.
Biotech Week; 12/16/2009; 981 words; ...Intelligence). CBI and Medical Meetings magazine's speaker faculty includes some of the country's leading experts in pharmaceutical meeting planning...Millennium: The Takeda Oncology Group, Novo Nordisk, Inc., Orlando, Pfizer Inc, PricewaterhouseCoopers...

TEDA Wins 12 Consecutive Championships in Appraisal of Investment Environment of State-level Development Zones.
China Weekly News; 12/15/2009; 1162 words; ...mainly include Samsung's LED project with a total...Zoomlion Finance & Leasing's US$80 million project...and Novozymes Biopharma's US$70 million project...strong growth momentum. Novo Nordisk increased its investment...

Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013.
Diabetes Week; 12/14/2009; 1111 words; ...population, increased use of new generation antidiabetics such as Merck's Januvia, Novartis's Galvus, Sanofi-Aventis's Lantus and Novo Nordisk's Levemir and the launch of several novel agents like Amylin/Eli Lilly/Alkermes's Byetta...

Novo Ramps Up for Purchase of Additional BioMimetic Therapeutics Shares.
Health & Beauty Close-Up; 12/11/2009; 532 words; ...be adopted by any of the Company's officers or directors from time to...modification or termination of such plans. Novo A/S is a private limited liability company fully owned by the Novo Nordisk Foundation. BioMimetic Therapeutics...